|Expense Ratio (net)||0.77%|
|Last Cap Gain||0.00|
|Morningstar Risk Rating||Average|
|5y Average Return||N/A|
|Average for Category||N/A|
|Inception Date||Dec 29, 1995|
As the economy is at full throttle, adding mutual funds from sectors like construction, healthcare as well as manufacturing seems prudent.
Trump's pro-business policies gave a boost to sectors like healthcare and technology, which makes investment in these sector-based mutual funds a wise choice
Broadly encouraging economic conditions, favorable tax policies and a higher number of approvals from the FDA makes healthcare mutual funds a hotbed of money
Broadly encouraging economic conditions, favorable policies and a higher number of approvals from the FDA makes healthcare mutual funds a hotbed of money.
Biotech stocks have taken off since President Trump took office. Through the end of July, the iShares Biotech ETF is up almost 19%, well ahead of broader market benchmarks. If you are thinking of investing in biotech stocks after this rally, here's what you need to know.